[Federal Register Volume 86, Number 175 (Tuesday, September 14, 2021)]
[Notices]
[Pages 51167-51168]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19761]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Immuno-Oncology Research.
    Date: October 14-15, 2021.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Maria Elena Cardenas-Corona, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301-867-5309, 
<a href="/cdn-cgi/l/email-protection#264b47544f470845475442434847550b45495449484766484f4e08414950"><span class="__cf_email__" data-cfemail="80ede1f2e9e1aee3e1f2e4e5eee1f3ade3eff2efeee1c0eee9e8aee7eff6">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR 19-367: Maximizing Investigators' Research Award.
    Date: October 14, 2021.
    Time: 3:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anita Szajek, Scientific Review Officer, Center 
for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 
301-827-6276, <a href="/cdn-cgi/l/email-protection#f3929d9a8792dd808992999698b39d9a9bdd949c85"><span class="__cf_email__" data-cfemail="88e9e6e1fce9a6fbf2e9e2ede3c8e6e1e0a6efe7fe">[email protected]</span></a>.

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group; Lung Injury, Repair, and Remodeling Study 
Section.
    Date: October 18-19, 2021.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Ghenima Dirami, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD 
20892, 240-498-7546, <a href="/cdn-cgi/l/email-protection#4b2f22392a26222c0b28383965252223652c243d"><span class="__cf_email__" data-cfemail="e4808d9685898d83a4879796ca8a8d8cca838b92">[email protected]</span></a>.

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Molecular Neuropharma- cology 
and Signaling Study Section.
    Date: October 18-19, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Vanessa S. Boyce, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Rm. 4016F, MSC 7812, Bethesda, MD 
20892, (301) 435-0908, <a href="/cdn-cgi/l/email-protection#cdafa2b4aea8bbbe8daebebfe3a3a4a5e3aaa2bb"><span class="__cf_email__" data-cfemail="ed8f82948e889b9ead8e9e9fc3838485c38a829b">[email protected]</span></a>.

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group; Health Promotion in Communities Study 
Section.
    Date: October 18-19, 2021.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Helena Eryam Dagadu, MPH, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3137, Bethesda, MD 20892, 301-
435-1266, <a href="/cdn-cgi/l/email-protection#9cf8fdfbfdf8e9f4f9dcffefeeb2f2f5f4b2fbf3ea"><span class="__cf_email__" data-cfemail="ec888d8b8d88998489ac8f9f9ec2828584c28b839a">[email protected]</span></a>.

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Cancer Immunopathology and Immunotherapy Study 
Section.
    Date: October 18-19, 2021.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Zhang-Zhi Hu, M.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6186, MSC 7804, Bethesda, MD 20892, (301) 594-
2414, <a href="/cdn-cgi/l/email-protection#a8c0ddd2c0ddc9c6cfe8cbdbda86c6c1c086cfc7de"><span class="__cf_email__" data-cfemail="86eef3fceef3e7e8e1c6e5f5f4a8e8efeea8e1e9f0">[email protected]</span></a>.

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group; Bacterial Pathogenesis Study Section.
    Date: October 18-19, 2021.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Marci Scidmore, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 
20892, 301-435-1149, <a href="/cdn-cgi/l/email-protection#9bf6fae9f8f2b5e8f8f2fff6f4e9fedbf5f2f3b5fcf4ed"><span class="__cf_email__" data-cfemail="5f323e2d3c36712c3c363b32302d3a1f31363771383029">[email protected]</span></a>.

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Cancer Biomarkers Study Section.
    Date: October 18-19, 2021.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD 
20892, 301-357-9318, <a href="/cdn-cgi/l/email-protection#d5bbb2beb995b6a6a7fbbbbcbdfbb2baa3"><span class="__cf_email__" data-cfemail="5d333a36311d3e2e2f73333435733a322b">[email protected]</span></a>.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Brain Injury and Neurovascular Pathologies 
Study Section.
    Date: October 18-19, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Alexander Yakovlev, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD 
20892, 301-435-1254, <a href="/cdn-cgi/l/email-protection#7b021a10140d171e0d1a3b18080955151213551c140d"><span class="__cf_email__" data-cfemail="7d041c16120b11180b1c3d1e0e0f53131415531a120b">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


[[Page 51168]]


    Dated: September 8, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-19761 Filed 9-13-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>